Business Model and Financial Strategy DecisionsLicensing, M&A, partnering, scaling-up, IPO and m
register@taiwanbio.org.tw | www.bioasiataiwan.com | +886-2-7700-3883
©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.comLATEST
Transcenta Announces First Patient Dosed in the U.S. Study of Its First-In-Class Gremlin1 Targeting Antibody TST003 for the Treatment of Solid Tumors
2023-03-22